Synovathera™ is Strategic Growth AI’s dedicated therapeutics division, purpose-built to help pharma and biotech ventures compress time-to-evidence and approval-to-coverage.
We align regulatory strategy, payer evidence, and go-to-market execution to systematically raise probability of success (PoS), accelerate HTA outcomes, and de-risk launch across Canada and the U.S.
​
Our approach combines human-in-the-loop (HITL) analytics, Monte Carlo scenario bands, and operator-led execution to prioritize:
-
Indication sequencing
-
Price corridors
-
Access pathways
The result: pilots that convert into reimbursed revenue faster, with less risk, and clearer investor-grade forecasting.
We are dedicated to delivering high-quality, differentiated products to the Canadian market through strategic partnerships and tailored support. Our expertise includes:
​
-
Licensing & Commercializing Pharmaceuticals and Biologics to address specialized therapeutic needs.
-
Revitalizing Mature Brands to extend their lifecycle and unlock untapped value.
-
Maximizing Established Products with innovative marketing strategies that harness residual market potential.
-
Repositioning Tail Brands and Underpromoted Products to reignite profitability through targeted promotion.
-
Optimizing Legacy Products and Sunset Assets to meet loyal prescriber needs through strategic repositioning.
As an innovative partner, we collaborate closely with our clients to successfully launch new brands, ensuring seamless entry into the Canadian market while maximizing impact and market adoption.
​
Business Development
At Synovathera, our business development approach is focused on building strong, collaborative partnerships across the healthcare ecosystem. We work closely with industry leaders, government agencies, advocacy groups, key opinion leaders, academic institutions, and clinical organizations to drive innovation and ensure groundbreaking therapies reach the market and the patients who need them most.
Through flexible licensing, marketing and commercialization opportunities, we empower companies to expand their impact. Synovathera navigates complex regulatory pathways, advocates for patient needs, and brings your innovation to market with success.
Strategy
We focus on commercializing products not yet launched in Canada, new unique medications and late-stage market-ready products. Our approach prioritizes:
-
Solutions that address unmet needs in Canadian healthcare.
-
Offerings that provide value to patients and healthcare professionals.
-
Opportunities that align with our internal synergies.
-
Products that support creative marketing strategies.
Our goal is to help bring life-changing therapies to market, ensuring your innovations make a real impact.
​
Sales and Marketing
​
Our dedicated sales and marketing team, with extensive product launch experience, collaborates closely with healthcare professionals to increase brand visibility and product adoption in the Canadian market.
​
Therapeutic Areas ​
-
Rare Disease, CNS, Oncology, Specialty
Market Access
Synovathera leverages extensive experience in Canadian reimbursement to ensure streamlined market access for our partners. Skilled in navigating key agencies like CADTH, INESSS, PMPRB, and pCPA, we support our partners at every step—from regulatory and pricing compliance to securing positive assessments.
Our team has a strong track record of successful launch prices and favourable reimbursement outcomes. Synovathera delivers the strategic support necessary to achieve optimal pricing, broad coverage, and sustained market success for therapies in Canada.
​
Regulatory
​
Synovathera expertly navigates Canada’s regulatory and compliance landscape, ensuring products meet high standards for safety, efficacy, and quality. Our team is well-versed in Health Canada and PMPRB requirements, guiding partners through regulatory submissions, post-market surveillance, and strict compliance practices. By staying updated on regulatory changes, Synovathera mitigates risks and streamlines approvals, creating an efficient pathway for bringing innovations to the Canadian market.
​
​Our experienced management team boasts a proven track record in go-to-market strategies, marketing, clinical development, regulatory approvals, and the successful commercialization of both innovative products and established brands.
As a trusted partner to SMEs and global pharmaceutical and biotechnology companies, Synovathera delivers comprehensive support—from strategic planning to full-scale commercialization. We help our partners unlock the full potential of their innovations and legacy products in the Canadian market, leveraging our extensive network and expertise.
Reach out today to explore collaborative opportunities and drive lasting success together.
Professional Networks
UBC Entrepreneurship • BC Tech • AIinBC • Life Sciences BC • Healthtech Partnering